SCHEMBL238226

SCHEMBL238226

CC(C)c1cc2ncc3cc(-c4ccsc4)c(=O)[nH]c3n2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 1/20 0.38
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35
DRD2 P14416 1/20 0.35
HTR6 P50406 1/20 0.35
BTK Q06187 1/20 0.35
FYN P06241 1/20 0.34
PDE10A Q9Y233 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
PLAT P00750 1/20 0.33
CYP2A6 P11509 1/20 0.33
MEN1 O00255 1/20 0.32
GFER P55789 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL238239 0.87 BTK (0.38) CDK5CDK5R1USP2ALDH1A1PKM
SCHEMBL237826 0.84 MET (0.38) KDM5BALDH1A1BTKRAB9AADORA3
SCHEMBL234906 0.84 BTK (0.36) CDK5CDK5R1USP2ALDH1A1PKM
SCHEMBL236682 0.81 KDM5B (0.38) KDM5BALDH1A1BTKFYNPDE10A
SCHEMBL237827 0.80 NPC1 (0.44) CDK5CDK5R1ALDH1A1FYNRAB9A
SCHEMBL240034 0.77 KDM5B (0.38) KDM5BBTKADORA3PLAT
SCHEMBL239636 0.76 DRD2 (0.36) CDK5CDK5R1DRD2HTR6BTK
SCHEMBL237778 0.69 POLB (0.47) USP2ALDH1A1POLBRAB9APLAT
SCHEMBL238920 0.69 NPC1 (0.56) ALDH1A1RAB9AMEN1KMT2A
SCHEMBL236540 0.68 AURKA (0.38) ALDH1A1PKMRAB9AADORA3GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406250-B1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME (US) 2015-08-12 EP disclosed
EP-2406250-B1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME (US) 2015-08-12 EP disclosed
US-8614221-B2 Inhibitors of Akt activity MERCK SHARP & DOHME CORP. (US) 2013-12-24 US disclosed
US-20120004240-A1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME LLC 2012-01-05 US disclosed
US-20120004240-A1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME LLC 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004240-A1 INHIBITORS OF AKT ACTIVITY PIK3CD, PIK3CA, PIK3R5 KDM5B 2079/4885CDK5 70/4885CDK5R1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.